Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
43.48
-0.21 (-0.48%)
Nov 21, 2024, 4:00 PM EST - Market closed
Mirum Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 2,087 | 1,376 | 719 | 486 | 511 | 553 | |
| Market Cap Growth | 53.74% | 91.51% | 47.79% | -4.80% | -7.70% | - | |
| Enterprise Value | 2,120 | 1,378 | 535 | 299 | 380 | 429 | |
| Last Close Price | 43.48 | 29.52 | 19.50 | 15.95 | 17.46 | 24.52 | |
| PS Ratio | 6.68 | 7.38 | 9.32 | 25.40 | - | - | |
| PB Ratio | 8.99 | 5.53 | 5.06 | 4.04 | 2.97 | 4.25 | |
| P/TBV Ratio | - | - | 8.65 | 4.79 | 2.97 | 4.25 | |
| EV/Sales Ratio | 6.91 | 7.39 | 6.95 | 15.62 | - | - | |
| Debt / Equity Ratio | 1.37 | 1.24 | 0.02 | 0.02 | 0.02 | 0.03 | |
| Asset Turnover | 0.47 | 0.37 | 0.24 | 0.07 | - | - | |
| Inventory Turnover | 3.83 | 3.37 | 3.50 | - | - | - | |
| Quick Ratio | 3.05 | 4.07 | 2.71 | 3.76 | 12.56 | 8.92 | |
| Current Ratio | 3.34 | 4.45 | 2.94 | 3.91 | 12.80 | 9.13 | |
| Return on Equity (ROE) | -39.84% | -83.65% | -103.46% | -57.47% | -68.29% | -60.80% | |
| Return on Assets (ROA) | -9.10% | -13.65% | -25.33% | -40.48% | -33.64% | -34.44% | |
| Return on Capital (ROIC) | -10.65% | -19.46% | -61.42% | -72.70% | -42.14% | -38.76% | |
| Earnings Yield | -4.78% | -11.88% | -18.88% | -17.27% | -20.22% | -9.50% | |
| FCF Yield | -0.11% | -5.16% | -16.76% | -27.31% | -17.49% | -7.16% | |
| Buyback Yield / Dilution | -22.57% | -20.31% | -12.07% | -20.08% | -119.84% | -1177.21% | |
| Total Shareholder Return | -22.57% | -20.31% | -12.07% | -20.08% | -119.84% | -1177.21% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.